Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Rosa Morros

Biographic Data

ID9019865
NAMERosa Morros
GIVEN NAMESRosa
FAMILY NAMEMorros
SIGNATUREMORROS R
AFFILIATIONSUniversitat Autonòma de Barcelona
ORCID0000-0001-6752-8748
VERIFIEDYes
TOTAL WORKS3
TOTAL CITATIONS0
AUTHOR COUNT3
EDITOR COUNT0
FIRST PUBLICATION YEAR2025
LATEST PUBLICATION YEAR2026
H-INDEX0
  • Gut microbiome shift in long Covid: Impact of disease and montelukast treatment

    Open Access•Paula Camps-Massa, Judit Pérez-Mormeneu et al.•ARTICLE•Journal of Global Health•2026

    Background: Long COVID-19 is a post-infectious syndrome with persistent symptoms that can involve multiple organ systems. Evidence suggests that SARS-CoV-2 infection may disrupt gut microbiome composition, potentially contributing to long-term effects. As treatment remains symptom-based, interest has grown in repurposing drugs like montelukast. However, non-antibiotic medications may also alter gut microbial communities, raising questions about t…

  • Efectividad Del Tratamiento Crónico Con Estatinas en La Incidencia De Neumonía Adquirida en La Comunidad

    Open Access•Diana Toledo, Àurea Cartanyà‐Hueso et al.•ARTICLE•Gaceta Sanitaria•2025

  • Efectividad Del Tratamiento Crónico Con Estatinas en La Incidencia Y Gravedad De La Gripe

    Open Access•Diana Toledo, Àurea Cartanyà‐Hueso et al.•ARTICLE•Gaceta Sanitaria•2025

No prominent works on this page.

  • Efectividad Del Tratamiento Crónico Con Estatinas en La Incidencia De Neumonía Adquirida en La Comunidad

    Open Access•Diana Toledo, Àurea Cartanyà‐Hueso et al.•ARTICLE•Gaceta Sanitaria•2025

  • Efectividad Del Tratamiento Crónico Con Estatinas en La Incidencia Y Gravedad De La Gripe

    Open Access•Diana Toledo, Àurea Cartanyà‐Hueso et al.•ARTICLE•Gaceta Sanitaria•2025

  • Gut microbiome shift in long Covid: Impact of disease and montelukast treatment

    Open Access•Paula Camps-Massa, Judit Pérez-Mormeneu et al.•ARTICLE•Journal of Global Health•2026

    Background: Long COVID-19 is a post-infectious syndrome with persistent symptoms that can involve multiple organ systems. Evidence suggests that SARS-CoV-2 infection may disrupt gut microbiome composition, potentially contributing to long-term effects. As treatment remains symptom-based, interest has grown in repurposing drugs like montelukast. However, non-antibiotic medications may also alter gut microbial communities, raising questions about t…

MEDLINE (2 works) · Chemotherapy (1 works) · Coronavirus (1 works) · Disease (1 works) · Gut flora (1 works) · Gut microbiome (1 works) · Gut microbiota and health (1 works) · Immune responses and vaccinations (1 works) · Long-Term Effects of COVID-19 (1 works) · Medical Research and Treatments (1 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae